Myriam Curet McAdams - 28 Oct 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
28 Oct 2025
Net transactions value
-$2,417,442
Form type
4
Filing time
29 Oct 2025, 19:48:57 UTC
Previous filing
25 Jul 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 29 Oct 2025 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1,218,954 +5,030 +1425% $242.34 5,383 28 Oct 2025 Direct F1
transaction ISRG Common Stock Sale $2,758,580 -5,030 -93% $548.43 353 28 Oct 2025 Direct F1, F2
transaction ISRG Common Stock Options Exercise $264,487 +1,153 +327% $229.39 1,506 28 Oct 2025 Direct F1
transaction ISRG Common Stock Sale $632,334 -1,153 -77% $548.43 353 28 Oct 2025 Direct F1, F2
transaction ISRG Common Stock Options Exercise $288,073 +1,379 +391% $208.90 1,732 28 Oct 2025 Direct F1
transaction ISRG Common Stock Sale $756,279 -1,379 -80% $548.43 353 28 Oct 2025 Direct F1, F2
transaction ISRG Common Stock Options Exercise $26,112 +125 $208.90 125 29 Oct 2025 Direct F1
transaction ISRG Common Stock Sale $67,875 -125 -100% $543.00 0 29 Oct 2025 Direct F1
holding ISRG Common Stock 353 28 Oct 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,379 -69% $0.000000 626 28 Oct 2025 Common Stock 1,379 $208.90 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -125 -20% $0.000000 501 29 Oct 2025 Common Stock 125 $208.90 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,153 -41% $0.000000 1,676 28 Oct 2025 Common Stock 1,153 $229.39 Direct F1, F4
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,030 -100% $0.000000 0 28 Oct 2025 Common Stock 5,030 $242.34 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F4 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.